The results showed that icariin could reduce ROS, MMP, and apoptosis levels and increase PI3K and p‐AKT levels in adriamycin‐induced NRK‐52e cells, suggesting that icariin may be the active ingredient of EPI in the treatment of adriamycin‐induced nephropathy. Here, AKT1 is linked to kidney disorder.